首页
产品目录
分子砌块
按官能团
羧酸类
(3R,5R)-7-[2-(4-氟苯基)-4-[(2-羟基苯基)氨基甲酰基]-5-异丙基-3-(氘代-d5-苯基)-1H-吡咯-1-基]-3,5-二羟基庚酸单钙盐
(3R,5R)-7-[2-(4-氟苯基)-4-[(2-羟基苯基)氨基甲酰基]-5-异丙基-3-(氘代-d5-苯基)-1H-吡咯-1-基]-3,5-二羟基庚酸单钙盐
monocalcium mono((3R,5R)-7-(2-(4-fluorophenyl)-4-((2-hydroxyphenyl)carbamoyl)-5-isopropyl-3-(phenyl-d5)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)
产品编号 :
ACLWYC677
Cas No. :
265989-47-7
包装规格
纯度
目录价
会员专享价
库存
数量
抱歉,暂无牌价信息
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
265989-47-7
中文名称
(3R,5R)-7-[2-(4-氟苯基)-4-[(2-羟基苯基)氨基甲酰基]-5-异丙基-3-(氘代-d5-苯基)-1H-吡咯-1-基]-3,5-二羟基庚酸单钙盐
英文名称
monocalcium mono((3R,5R)-7-(2-(4-fluorophenyl)-4-((2-hydroxyphenyl)carbamoyl)-5-isopropyl-3-(phenyl-d5)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)
别名
Ortho-Hydroxy atorvastatin calcium salt;Ortho-Hydroxy atorvastatin-d5 calcium salt;calcium,(3S,5S)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-(2,3,4,5,6-pentadeuteriophenyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate;O-Hydroxy Atorvastatin D5;[2H10]-di (2-Hydroxy Atorvastatin) Calcium Salt;Ortho-Hydroxy atorvastatin calcium salt USP/EP/BP;2H5]-o-Hydroxyatorvastatin calcium salt;D5-o-Hydroxyatorvastatin calcium salt
标准英文名
monocalcium mono((3R,5R)-7-(2-(4-fluorophenyl)-4-((2-hydroxyphenyl)carbamoyl)-5-isopropyl-3-(phenyl-d5)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate)
分子式
C3 3 H3 4 CaFN2 O6 +
分子量
618.75
精确分子量
618.23
SMILES
[2H]C1=C([2H])C([2H])=C(C2=C(C3=CC=C(F)C=C3)N(CC[C@@H](O)C[C@@H](O)CC(=O)[O-])C(C(C)C)=C2C(=O)NC2=CC=CC=C2O)C([2H])=C1[2H].[Ca+2]
标准SMILES
[Ca+2].[2H]C1=C(C2C(=C(C(C)C)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C=2C2C=CC(F)=CC=2)C(=O)NC2=CC=CC=C2O)C([2H])=C([2H])C([2H])=C1[2H]
用途
Ortho-Hydroxy atorvastatin calcium salt is a metabolite of atorvastatin calcium, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, which significantly reduces cholesterol synthesis and accumulation in the body; it contributes to approximately 70% of the pharmacological activity and is used clinically for the treatment of hypercholesterolemia.
InChIKey
FMMSIVYEKYZYQS-FHADZASJSA-M